Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;19(4):399-408.
doi: 10.1007/s12094-016-1559-0. Epub 2016 Oct 19.

Telomeres and telomerase in the clinical management of colorectal cancer

Affiliations
Review

Telomeres and telomerase in the clinical management of colorectal cancer

C Piñol-Felis et al. Clin Transl Oncol. 2017 Apr.

Abstract

Colorectal cancer (CRC) is the third most common cancer worldwide. Our aim is to describe the state of the art about the role of telomeres and telomerase in the clinical management of CRC and its potential utility as prognostic and diagnostic biomarkers and targets of new treatments. Telomere length could be a new diagnostic marker as an anomalous behavior is observed in peripheral blood cells when CRC patients and healthy people are compared. Moreover, telomeres and telomerase may be used as diagnostic markers considering that universal changes appear along the CRC process. Currently, new therapeutic cancer approaches are focused on inhibiting the maintenance of telomere length, choosing as targets telomerase -or its subunits- or the Shelterin complex. The goal of these therapies is the shortening of telomeres and the induction of cell senescence. Telomeres and telomerase emerge as useful molecular tools in the clinical management of CRC.

Keywords: Colorectal cancer; Colorectal cancer therapy; Diagnostic marker; Prognostic marker; Telomerase activity; Telomere length.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
    1. Cell. 1997 Aug 22;90(4):785-95 - PubMed
    1. Colorectal Dis. 2002 Nov;4(6):441-6 - PubMed
    1. Contemp Oncol (Pozn). 2014;18(1):1-6 - PubMed
    1. Cancer. 2002 Nov 1;95(9):1834-9 - PubMed

MeSH terms

LinkOut - more resources